Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Dose-Finding Study on Senescence in Healthy Volunteers
2025-522379-26-00Phase 2Withdrawn
- Sponsor
- IRCCS Ospedale Policlinico San Martino
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of azithromycin in cellular senescence and inflammaging, sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoints: Change in senescent cell abundance in blood cells and Change in serum markers of aging/inflammaging. Planned start Sep 2025; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
cellular senescenceinflammaging
Beyond the preview
Go deeper on 2025-522379-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522379-26-00.